COMMUNIQUÉS West-GlobeNewswire

Rexahn Receives Notice of Allowance for U.S. Patent Covering RX-3117 Use in a Broad Range of Tumor Types
04/02/2019
Broadens Patent Protection for RX-3117 to 2036 ROCKVILLE, Md., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative [...]
Genesis HealthCare Enters Into Partnership to Buy Back Real Estate Historically Leased From Welltower Inc.
04/02/2019
Enters into new lease agreement with purchase option for 15 facilities; 7 facilities divested KENNETT SQUARE, Pa., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Genesis HealthCare (Genesis or the Company), one of the nation’s [...]
Allakos to Host Investor Day on February 19 in New York City
04/02/2019
REDWOOD CITY, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing AK002 for the treatment of eosinophil and mast cell related diseases, today announced that it will [...]
Progressive Care Inc. Speaks About Alternative Medicine to Combat the Opioid Crisis
04/02/2019
Company Secured Media Coverage in Insider Financial and Cannabis Radio Show MIAMI, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, [...]
Tabula Rasa HealthCare Announces Upcoming Launch of MedWise™ 2.0
04/02/2019
Latest version of MedWise™ offers seamless integration with Electronic Health Records to allow providers access to patient safety interventions at the point of care MOORESTOWN, N.J., Feb. 04, 2019 (GLOBE NEWSWIRE) -- [...]
Amedisys Closes on Acquisition of Compassionate Care Hospice
04/02/2019
Company Becomes Third Largest Hospice Provider in America Announces Expanded $725 million Senior Secured Credit Facility BATON ROUGE, La., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (the “Company” or “Amedisys”) ( [...]
Aleafia Health to Accelerate Research Division with Appointment of Product Data Science Fellow
04/02/2019
Research Revenue Totalled $0.6 Million in Q3 2018 Product Data Science Fellow to Lead Evidence-Based Product Research via Proprietary, 10M Point Patient Dataset TORONTO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Aleafia Health [...]
International group of experts revisits the value of traditional Helicobacter tests (13C urea breath test and stool antigen test) in their critical review
04/02/2019
Biohit Oyj press release 04.02.2019 International group of multidisciplinary experts from China, Italy, Estonia and Finland, has written a comprehensive and critical review on advantages and limitations of the [...]
LIDDS research activities in intratumoral immunotherapy are in line with leading oncology expert recommendations
04/02/2019
The European Society for Medical Oncology (ESMO) sponsored paper provides recommendations on the harmonization of methodologies, definitions and data collection that supports LIDDS research into delivering intratumoral [...]
Calithera Biosciences Completes Patient Enrollment in Randomized Phase 2 ENTRATA Trial of Telaglenastat (CB-839) and Everolimus in Renal Cell Carcinoma
04/02/2019
Top line results expected in second half of 2019 SOUTH SAN FRANCISCO, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering [...]
CureVac Appoints Stefan Mueller, Ph.D., as Vice President Preclinical
04/02/2019
Drug development veteran to focus on advancing the company’s preclinical portfolio of programs in naturally optimized mRNA TÜBINGEN, Germany and BOSTON, Feb. 04, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated [...]
Athenex Announces Late-Breaking Oral Presentation of KX2-391 Ointment in Two Phase III Studies at the American Academy of Dermatology Annual Meeting
04/02/2019
Results from Phase III pivotal studies to be featured at Late-Breaking Research Program on March 2, 2019 BUFFALO, N.Y., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company [...]
Eloxx Pharmaceuticals to Present at the 2019 BIO CEO and Investor Conference in New York City on Monday, February 11, 2019
04/02/2019
WALTHAM, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
Optinose Announces License Agreement
04/02/2019
YARDLEY, Pa., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and [...]
EyePoint Pharmaceuticals Announces U.S. Commercial Launch of YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg
04/02/2019
- YUTIQ Indicated for the Treatment of Chronic Non-Infectious Posterior Segment Uveitis - WATERTOWN, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a specialty biopharmaceutical [...]
Northeast Scientific celebrates medical device remanufacturing success with a major reinvestment to bring its marketing, sales and customer service in-house
04/02/2019
WATERBURY, Conn., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Northeast Scientific, Inc. (NES), known for its advanced medical device remanufacturing successes for more than 13 years, continues its business growth and development [...]
Anavex Life Sciences to Present at the 2019 BIO CEO & Investor Conference
04/02/2019
NEW YORK, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
Radient Technologies Inc. Receives Standard Processing License from Health Canada
04/02/2019
EDMONTON, Alberta, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce it has received its Standard Processing License from [...]
Spero Therapeutics Announces FDA Acceptance of IND Application for SPR994
04/02/2019
CAMBRIDGE, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]

Pages